Phase 1: full-text search runs

Raw top results per question, for hand review
Published

September 25, 2026

Every question run against AY25-26 events with BM25 (pages + speaker notes, objectives, event title/description), without and with MeSH expansion. Generated by scripts/phase1_baseline.py.

Q01: Where do students learn the mechanisms of heart failure with reduced vs preserved ejection fraction?

Query heart failure reduced preserved ejection fraction · scope PCV AY25-26 · gold Heart Failure & Cardiomyopathy, Principles of Heart Failure Treatment, Week 5: Prework · recall@10 3/3

MeSH expansion added: Right Sided Heart Failure, Left Sided Heart Failure, Congestive Heart Failure, Left-Sided Heart Failure, Cardiac Failure, Hearts, Right-Sided Heart Failure, Myocardial Failure, Heart Decompensation

score course campus week event_title method title objective material top_file
2.89 PCV FCB 5 Heart Failure & Cardiomyopathy - FCB Lecture 1 1 0.89 FCB-PCV-Heart Failure and Cardiomyopathy-FA25-AC-FINAL.pptx
2.8 PCV AMC 5 Heart Failure & Cardiomyopathy - AMC Case-Based Instruction/Learning 0.8 1 1 Heart Failure and Cardiomyopathy - FINAL 2025.pptx
2.6 PCV FCB 6 Principles of Heart Failure Treatment - FCB Lecture 0.96 0.7 0.95 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf
2.4 PCV AMC 6 Principles of Heart Failure Treatment - AMC Lecture 0.77 0.7 0.93 Principles of Heart Failure Treatment - 2025 FINAL.pptx
2.08 PCV AMC 6 PCV Clinical Cases: Heart and Respiratory Failure - AMC Case-Based Instruction/Learning 0.89 0.54 0.65 FINAL PCV Cases Heart and Resp Failure Week 6 2025 - with answers, release AFTER.pptx
2.07 PCV FCB 6 Pathology Lab: Heart Failure and Cardiomyopathy - FCB Laboratory 0.92 0.58 0.57 6-00645-Cardiomyopathy Pathology_CONTENT_GCA_25.pdf
1.8 PCV AMC 6 Pathology Lab: Heart Failure and Cardiomyopathy - AMC Laboratory 0.79 0.58 0.43 AFTER_Heart Failure and Cardiomyopathy answers.pdf
1.78 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 0.82 0.97 PCV Heart failure prework w audio.pptx
1.42 PCV FCB 6 PCV Clinical Cases: Heart and Respiratory Failure - FCB Lecture 0.89 0.54 0 nan
1.41 PCV nan 6 PCV Clinical Cases: Heart and Respiratory Failure nan 0.88 0.54 0 nan
  • PCV wk5 Heart Failure & Cardiomyopathy - AMC — Heart Failure and Cardiomyopathy - FINAL 2025.pptx p.13: | # Heart Failure Basic Principles Heart Failure We think differently about: Left vs right heart failure Preserved vs reduced ejection fraction Left sided Right sided Picture 3 Prese
  • PCV wk5 PCV Week 5: Prework - AMC — PCV Heart failure prework w audio.pptx p.13: | # Introduction to Heart Failure Heart Failure Please read this chapter from Lilly’s Pathophysiology of Heart Disease which gives a good foundation for our discussion on types of heart failure this
  • PCV wk6 Principles of Heart Failure Treatment - FCB — 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf p.12: | 2 Heart failure ejection fraction: Reduced vs preserved

Q02: Where is HFrEF pharmacotherapy (guideline-directed therapy including SGLT2 inhibitors) taught?

Query HFrEF SGLT2 inhibitor · scope all courses AY25-26 · gold Principles of Heart Failure Treatment · recall@10 1/1

MeSH expansion added: Gliflozin, SGLT 2 Inhibitor, Sodium-Glucose Transporter 2 Inhibitor, Sodium Glucose Transporter 2 Inhibitors, Gliflozins, SGLT-2 Inhibitors, SGLT 2 Inhibitors, Sodium-Glucose Transporter 2 Inhibitors, Sodium Glucose Transporter 2 Inhibitor, SGLT2 Inhibitors, SGLT-2 Inhibitor

score course campus week event_title method title objective material top_file
2 PCV FCB 6 Principles of Heart Failure Treatment - FCB Lecture 0 1 1 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf
1.95 PCV AMC 6 Principles of Heart Failure Treatment - AMC Lecture 0 1 0.95 Principles of Heart Failure Treatment - 2025 FINAL.pptx
1.12 MSI AMC 3 Intro to Rheumatology & Arthritis - Osteoarthritis and Rheumatoid Arthritis - AMC Large Group 0 0.82 0.31 FINAL_BEFORE_Rheumatology for MSI - Arthritis Part 1_2_2_26.pptx
1.12 MSI FCB 3 Intro to Rheumatology & Arthritis - Osteoarthritis and Rheumatoid Arthritis - FCB Lecture 0 0.82 0.31 FINAL_BEFORE_FCB Rheumatology for MSI - Arthritis Part 1_2_2_26.pptx
0.97 FP AMC 5 Principles of Synaptic Pharmacology - AMC Lecture 0 0.67 0.3 Final_Before_SynapticPharm_06272025.pptx
0.96 PCV FCB 3 Atherosclerosis, Lipids & Antilipemic Pharmacology - FCB Lecture 0 0.64 0.32 3-00270-Atherosclerosis & Antilipemics_CONTENT_GCA_25.pdf
0.95 FP FCB 3 The Complement System - FCB Lecture 0 0.7 0.26 SLIDE DECK. 081224_The Complement System_BEFORE CLASS_FINAL (1).pptx
0.93 FP AMC 3 The Complement System - AMC Large Group 0 0.7 0.23 SLIDE DECK. 081425_Complement System_FINAL_BEFORE CLASS.pptx
0.92 FP FCB 5 Principles of Synaptic Pharmacology - FCB Lecture 0 0.67 0.26 5-00600-Principles of Synaptic Pharmacology_CONTENT_GCA_25.pdf
0.87 PCV AMC 3 Atherosclerosis, Lipids & Antilipemic Pharmacology - AMC Large Group 0 0.64 0.23 FINAL 2025 Lipids and Anti-lipidemic Pharmacology​ 2024.pptx
  • PCV wk6 Principles of Heart Failure Treatment - FCB — 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25.pdf p.70: | C Case 7: SGLT2 inhibitor in chronic heart failure A 64-year-old with chronic HFrEF and type 2 diabetes is started on empagliflozin. Why it matters clinically: SGLT2 inhibitors reduce hospitalizati
  • PCV wk Principles of Heart Failure Treatment - FCB — 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf p.70: | C Case 7: SGLT2 inhibitor in chronic heart failure A 64-year-old with chronic HFrEF and type 2 diabetes is started on empagliflozin. Why it matters clinically: SGLT2 inhibitors reduce hospitalizati
  • PCV wk6 Principles of Heart Failure Treatment - AMC — Principles of Heart Failure Treatment - 2025 FINAL.pptx p.31: | # Goals of therapy: Live longer, feel better | Heart failure with reduced ejection fraction | Heart failure with preserved ejection fraction | | — | — | | Mortality and symptom benefit: β-block

Q03: Where is the ECG introduced and where is it revisited?

Query ECG · scope PCV AY25-26 · gold Cardiac Conduction & ECG Intro, ECG Cases: Cardiac Dysrhythmias, ECG Cases: Chest Pain, Clinical Cases: ABG · recall@10 4/4

MeSH expansion added: Electrocardiograms, Electrocardiograph, 12-Lead ECG, 12 Lead EKG, 12-Lead ECGs, EKG, 12-Lead Electrocardiography, 12 Lead Electrocardiography, Electrocardiogram, 12 Lead ECG, 12-Lead EKGs

score course campus week event_title method title objective material top_file
2.76 PCV FCB 1 Cardiac Conduction & ECG Intro - FCB Lecture 1 0.81 0.95 1-00060-Cardiac Conduction & ECG Intro_CONTENT_GCA_25.pdf
2.52 PCV AMC 1 Cardiac Conduction & ECG Intro - AMC Lecture 0.71 0.81 1 Cardiac conduction and ECG intro 2025 FINAL.pptx
2.46 PCV AMC 3 ECG Cases: Chest Pain and Ischemia - AMC Case-Based Instruction/Learning 0.88 0.74 0.84 Ischemia ECG cases with answers - FINAL, release AFTER1.pptx
2.33 PCV AMC 1 PCV Clinical Cases: ABG, PFT, ECG - AMC Case-Based Instruction/Learning 0.65 0.85 0.82 Clinical Cases ABG-PFT-ECG 2025 - release to students AFTER event.pptx
2.19 PCV AMC 2 ECG Cases: Cardiac Dysrhythmias - AMC Case-Based Instruction/Learning 0.71 0.66 0.82 Cardiac Dysrhythmias Clin Cases 2025 Student version.pptx
2.16 PCV AMC 3 Acute Coronary Syndromes - Diagnosis & Management - AMC Large Group 0.45 0.78 0.94 Acute Coronary Syndromes Part 1 Bricker - Diagnosis 2025.pptx
1.87 PCV AMC 2 PCV Week 2: Prework - AMC Directed Independent Learning 0 1 0.87 ecg slide deck.pptx
1.78 PCV FCB 1 PCV Clinical Cases: ABG, PFT, ECG - FCB Lecture 0.92 0.85 0 nan
1.78 PCV AMC 1 PCV Week 1: Prework - AMC Directed Independent Learning 0 0.88 0.9 CV Week 1 Prework 3 of 3 - Intro to ECG.pptx
1.7 PCV FCB 3 ECG Cases: Chest Pain and Ischemia - FCB Lecture 0.96 0.74 0 nan
  • PCV wk3 Ischemia, Angina & Claudication - AMC — M1 Event material for ischemia, angina, claudication 2025 FINAL.pptx p.82: | # Coronary Vasospasm Content Placeholder 4 61 year-old female with multiple sclerosis is admitted for urosepsis. A norepinephrine infusion is started to maintain blood p
  • PCV wk1 Cardiac Conduction & ECG Intro - AMC — Cardiac conduction and ECG intro 2025 FINAL.pptx p.77: | FYI Slide! # 12 lead ECG : lead groupings The Coronary Arteries – ECG & ECHO Pin on Med - ECG Pin on Med - ECG ![Pin on Med - ECG](Picture2.jp
  • PCV wk1 Cardiac Conduction & ECG Intro - FCB — 1-00060-Cardiac Conduction & ECG Intro_CONTENT_GCA_25.pdf p.6: | LEARNING OBJECTIVE HELPER 4. AV Block Types: List and describe first-degree, second-degree (Mobitz I and II), and third-degree AV blocks, including characteristic ECG findings. 5. Bundle Branch Blo

Q04: Where are antiarrhythmic drug classes taught?

Query antiarrhythmic drugs · scope PCV AY25-26 · gold Pharmacology of Antidysrhythmics · recall@10 1/1

MeSH expansion added: Pharmaceuticals, Pharmaceutical Preparation, Anti Arrhythmia Drugs, Anti-Arrhythmia Drug, Antiarrhythmia Agent, Pharmaceutical Preparations, Anti Arrhythmia Agents, Antiarrhythmia Drug, Pharmaceutical, Anti-Arrhythmia Agents

score course campus week event_title method title objective material top_file
1.43 PCV FCB 2 Autonomic Regulation of the Cardiovascular System - FCB Lecture 0 1 0.43 2-00145-Autonomic CV Regulation_CONTENT_GCA_25.pdf
1 PCV AMC 2 Autonomic Regulation of the Cardiovascular System - AMC Lecture 0 1 0 nan
1 PCV AMC 2 Pharmacology of Antidysrhythmics - AMC Lecture 0 0 1 Zuckerman Rague Antidysrythmic 2025 FINAL.pptx
0.99 PCV AMC 2 PCV Week 2: Prework - AMC Directed Independent Learning 0 0 0.99 CV Week 2 Prework - AP, Arrhytmia, and Drug Intro w Audio.pptx
0.99 PCV FCB 2 Pharmacology of Antidysrhythmics - FCB Lecture 0 0 0.99 2-00180-Pharmacology of Antiarrhythmic Drugs_CONTENT_GCA_25.pdf
0.86 PCV AMC 6 Principles of Heart Failure Treatment - AMC Lecture 0 0.62 0.24 Principles of Heart Failure Treatment - 2025 FINAL.pptx
0.85 PCV FCB 6 Principles of Heart Failure Treatment - FCB Lecture 0 0.62 0.23 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf
0.8 PCV FCB 1 Action Potentials and Conduction - FCB Lecture 0 0 0.8 1-00050-Action Potentials & Conduction_CONTENT_GCA_25.pdf
0.71 PCV FCB 2 Overview of Dysrhythmias - FCB Lecture 0 0 0.71 2-00175-Abnormal Cardiac Electrophysiology_CONTENT_GCA_25.pdf
0.58 PCV AMC 3 Acute Coronary Syndromes - Diagnosis & Management - AMC Large Group 0 0 0.58 Acute Coronary Syndromes Part 2 Bricker - Complications and Management 2025.pptx
  • PCV wk2 Pharmacology of Antidysrhythmics - AMC — Zuckerman Rague Antidysrythmic 2025 FINAL.pptx p.18: | # Antiarrhythmics : overview Antiarrhythmic agent - Wikipedia ![Antiarrhythmic Drug Class Mnemonic, Medication List, Example Agents, and Effects on Action Potential — EZmed](Pictur
  • PCV wk2 Pharmacology of Antidysrhythmics - AMC — Draft_Before_Antidysrythmic_09192025.pptx p.110: | # Antiarrhythmics : overview Antiarrhythmic agent - Wikipedia ![Antiarrhythmic Drug Class Mnemonic, Medication List, Example Agents, and Effects on Action Potential — EZmed](Pictur
  • PCV wk2 Pharmacology of Antidysrhythmics - FCB — 2-00180-Pharmacology of Antiarrhythmic Drugs_CONTENT_GCA_25.pdf p.18: | 2 5 Class I Antiarrhythmic Drugs

Q05: Where do students learn to interpret arterial blood gases?

Query arterial blood gas interpretation · scope PCV AY25-26 · gold Blood Gas Analysis, Clinical Cases: ABG · recall@10 1/2 · missed Clinical Cases: ABG

score course campus week event_title method title objective material top_file
2.98 PCV FCB 1 Blood Gas Analysis: Gas Exchange & Respiratory Failure - FCB Lecture 1 1 0.98 1-00030-Blood Gas Analysis_CONTENT_GCA_25-26.pdf
2.75 PCV AMC 1 Blood Gas Analysis: Gas Exchange & Respiratory Failure - AMC Lecture 0.75 1 1 Blood Gas Analysis 2025 - FINAL.pptx
2.28 PCV FCB 1 Gas Exchange - FCB Lecture 0.57 0.89 0.81 1-00020-Gas Exchange_CONTENT_GCA_25.pdf
1.92 PCV AMC 1 Gas Exchange - AMC Case-Based Instruction/Learning 0.4 0.89 0.63 Gas Exchange Flipped Classroom 2025 - FINAL.pptx
1.74 PCV AMC 1 Normal Lung Histology & Pathology of Impaired Gas Exchange - AMC Case-Based Instruction/Learning 0.43 0.48 0.82 AFTER_Normal lung histology and pathology of gas exchange answers.pdf
1.67 PCV FCB 1 Normal Lung Histology & Pathology of Impaired Gas Exchange - FCB Lecture 0.47 0.48 0.72 1-00035-Lung Histology & Impaired Exchange_CONTENT_GCA_25-26.pdf
1.47 PCV AMC 1 Pulmonary + Systemic Circulation - AMC Lecture 0 0.61 0.86 Circulation talk 2025.pptx
1.38 PCV AMC 1 PCV Week 1: Prework - AMC Directed Independent Learning 0 0.55 0.82 Perfusion prework 2025 - FINAL.docx
1.32 PCV AMC 3 PCV Anatomy Lab 8: Coronary & Peripheral Circulation, Thoracic Innervation - AMC Laboratory 0.37 0.4 0.55 FINAL_before_PCV Wk3 Anatomy Lab #8_AY25-26.pptx
1.27 PCV FCB 1 Pulmonary + Systemic Circulation - FCB Lecture 0 0.61 0.65 FCB-PCV-Circulatory Physiology-FA25-AC.pptx
  • PCV wk1 Blood Gas Analysis: Gas Exchange & Respiratory Failure - AMC — Blood Gas Analysis 2025 - FINAL.pptx p.5: | # Why do we care about blood gas analysis? It forms the third pillar (along with PFT and imaging) of diagnosis of breathing disorders. In patients with respiratory failure, the type of respiratory
  • PCV wk1 Blood Gas Analysis: Gas Exchange & Respiratory Failure - FCB — 1-00030-Blood Gas Analysis_CONTENT_GCA_25-26.pdf p.4: | LO Learning Objectives • LO1: Discuss the Henderson-Hasselbalch Equation for Bicarbonate/CO2. • LO2: Discuss the determinants of minute and alveolar ventilation and how they affect CO2 removal. • L
  • PCV wk1 Pulmonary + Systemic Circulation - AMC — Circulation talk 2025.pptx p.11: | Picture 2 # Steps in the Pulmonary Circulation Arteries Carry deoxygenated blood from the right ventricle of the heart to the lungs. Capillary network Gas exchange Veins Carry oxyg

Q06: Where is spirometry and flow-volume loop interpretation taught?

Query spirometry flow volume loop · scope PCV AY25-26 · gold Pulmonary Function Testing · recall@10 1/1

MeSH expansion added: Spirometries

score course campus week event_title method title objective material top_file
2.49 PCV AMC 4 PCV Clinical Cases: Cardiac Physiology - AMC Case-Based Instruction/Learning 1 1 0.49 FINAL Cardiac Phys clinical cases answers version 2025 - release after session.pptx
2.05 PCV AMC 1 Pulmonary Function Testing - AMC Lecture 0.49 0.56 1 PCV PFTs Release AFTER lecture.pptx
1.79 PCV FCB 1 Lung Mechanics - FCB Lecture 0 0.95 0.84 1-00015-Lung Mechanics_CONTENT_GCA_25.pdf
1.77 PCV AMC 1 The Cardiac Cycle - AMC Lecture 0.61 0.6 0.56 Cardiac Cycle 2025 FINAL.pptx
1.59 PCV AMC 1 PCV Week 1: Prework - AMC Directed Independent Learning 0 0.94 0.65 CV Week 1 Prework 1 of 3 - Intro to CV Phys.pptx
1.55 PCV FCB 1 Pulmonary Function Testing - FCB Lecture 0 0.56 0.99 1-00025-Pulmonary Function Tests_CONTENT_GCA_25.pdf
1.4 PCV AMC 1 Lung Mechanics - AMC Case-Based Instruction/Learning 0 0.95 0.45 Lung Mechanics Slides -2025 - FINAL.pptx
1.33 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 0.85 0.48 PCV Heart failure prework w audio.pptx
1.14 PCV FCB 1 Pulmonary + Systemic Circulation - FCB Lecture 0 0.62 0.52 FCB-PCV-Circulatory Physiology-FA25-AC.pptx
1.13 PCV FCB 1 The Cardiac Cycle - FCB Lecture 0 0.6 0.53 FCB-PCV-Cardiac cycle-FA25-AC.pptx
  • PCV wk1 Pulmonary Function Testing - AMC — PCV PFTs Make available BEFORE lecture.pptx p.29: | Picture 1 Spirometry | Flow-volume loop Peak Flow Depicts airflow vs volume Uses: Helpful in identifying patterns of disease Can identify large airway obstruction (i.e. in the trac
  • PCV wk1 Pulmonary Function Testing - AMC — PCV PFTs Release AFTER lecture.pptx p.32: | Picture 1 Spirometry | Flow-volume loop Peak Flow Depicts airflow vs volume Uses: Helpful in identifying patterns of disease Can identify large airway obstruction (i.e. in the trac
  • PCV wk1 Pulmonary Function Testing - FCB — 1-00025-Pulmonary Function Tests_CONTENT_GCA_25.pdf p.40: | Q’s Question A 62-year-old individual with progressive hoarseness is referred for pulmonary function testing. The flow- volume loop demonstrates flattening of both the inspiratory and expiratory li

Q07: Where is the Frank-Starling mechanism taught?

Query Frank-Starling · scope PCV AY25-26 · gold The Cardiac Cycle, Cardiac and Smooth Muscle Physiology, Week 1: Prework · recall@10 3/3

MeSH expansion added: Mynahs, Oxpeckers, Oxpecker, Starlings, Sturnidae, Mynah

score course campus week event_title method title objective material top_file
1.79 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 1 0.79 PCV Heart failure prework w audio.pptx
1.79 PCV FCB 1 Cardiac and Smooth Muscle Physiology - FCB Lecture 0 0.86 0.93 1-00055-Cardiac & Smooth Muscle Physiology_CONTENT_GCA_25.pdf
1.36 PCV AMC 1 Cardiac and Smooth Muscle Physiology - AMC Lecture 0 0.86 0.5 FINAL Cardiac and Smooth Muscle 2025 - FINAL.pptx
1.23 PCV AMC 1 Pulmonary + Systemic Circulation - AMC Lecture 0 0.91 0.32 Circulation talk 2025.pptx
1.1 PCV FCB 1 Pulmonary + Systemic Circulation - FCB Lecture 0 0.91 0.19 FCB-PCV-Circulatory Physiology-FA25-AC.pptx
1 PCV FCB 5 PCV Week 5: Prework - FCB Directed Independent Learning 0 1 0 nan
1 PCV AMC 6 PCV Clinical Cases: Heart and Respiratory Failure - AMC Case-Based Instruction/Learning 0 0 1 FINAL PCV Cases Heart and Resp Failure Week 6 2025 - student version, release BEFORE.pptx
0.99 PCV AMC 1 The Cardiac Cycle - AMC Lecture 0 0 0.99 Cardiac Cycle 2025 FINAL.pptx
0.86 PCV FCB 1 The Cardiac Cycle - FCB Lecture 0 0 0.86 FCB-PCV-Cardiac cycle-FA25-AC.pptx
0.74 PCV AMC 1 PCV Week 1: Prework - AMC Directed Independent Learning 0 0 0.74 CV Week 1 Prework 1 of 3 - Intro to CV Phys.pptx
  • PCV wk6 PCV Clinical Cases: Heart and Respiratory Failure - AMC — FINAL PCV Cases Heart and Resp Failure Week 6 2025 - student version, release BEFORE.pptx p.17: | # 3B. Draw a normal Frank-Starling curve and what you think this patient’s curve looks like. How would the treatments affect the Frank-Starling curve?
  • PCV wk6 PCV Clinical Cases: Heart and Respiratory Failure - AMC — FINAL PCV Cases Heart and Resp Failure Week 6 2025 - with answers, release AFTER.pptx p.25: | # 3B. Draw a normal Frank-Starling curve and what you think this patient’s curve looks like. How would the treatments affect the Frank-Starling curve?
  • PCV wk1 The Cardiac Cycle - AMC — Cardiac Cycle 2025 FINAL.pptx p.46: | # Inotropy and Frank-Starling curves Picture 5 Decreased inotropy shifts the Frank-Starling curve downward (lower slope) Result: For a given preload, SV will be lower Increased ino

Q08: Where is tuberculosis diagnosis and treatment covered?

Query tuberculosis · scope all courses AY25-26 · gold Tuberculosis, Immunocompromised · recall@10 1/2 · missed Immunocompromised

MeSH expansion added: Koch Disease, Kochs Disease, Mycobacterium tuberculosis Infection, Mycobacterium tuberculosis Infections, Tuberculoses, Koch’s Disease

score course campus week event_title method title objective material top_file
2.9 PCV FCB 5 Tuberculosis - FCB Lecture 1 0.95 0.96 Tuberculosis (2025) - posted.pptx
2.54 PCV AMC 5 Tuberculosis - AMC Lecture 0.62 0.95 0.97 tuberculosis 2025.pptx
1.67 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 1 0.67 PCV CT Chest Prework w audio.pptx
1.58 FP FCB 2 Microbiology & Inflammation: Host-Pathogen Interaction - FCB Lecture 0 0.9 0.68 Microbiology Inflammation. Host Pathogen Interaction - 2025.pptx
1.57 FP AMC 2 Microbiology & Inflammation: Host-Pathogen Interaction - AMC Large Group 0 0.9 0.67 SLIDE DECK. 080725_Integration. Host Pathogen_FINAL_BEFORE CLASS.pptx
1 PCV FCB 5 PCV Week 5: Prework - FCB Directed Independent Learning 0 1 0 nan
1 FP AMC 2 Bacterial Structure, Function & Pathogenesis - AMC Lecture 0 0 1 Micro2 - Bacterial Structure-function-pathogenesis updated.pptx
0.97 FP FCB 3 Histopathology of Tissue Injury & Wound Healing - FCB Lecture 0 0 0.97 FCB_FP_Histopathology of Tissue Injury & Wound Healing_NK.pptx
0.93 PCV AMC 4 Immunology: Pulmonary Host Defense - AMC Large Group 0 0 0.93 PCV. Pulmonary Host Defense 2025_before class_FINAL.pptx
0.91 FP AMC 3 Histopathology of Tissue Injury & Wound Healing - AMC Lecture 0 0 0.91 FINAL_BEFORE_Week 3 Histopathology of Tissue Injury and Wound Healing student version.pptx
  • FP wk2 Bacterial Structure, Function & Pathogenesis - AMC — Micro2 - Bacterial Structure-function-pathogenesis updated.pptx p.18: | # Mycobacteria Mycobacterium tuberculosis (causes tuberculosis) Mycobacterium leprae (leprosy) Mycobacterium bovis (bovine tuberculosis) Mycobacterium avium complex (chronic lung disease; dissemina
  • FP wk2 Bacterial Structure, Function & Pathogenesis - AMC — Micro2 - Bacterial Structure-function-pathogenesis.pptx p.18: | # Mycobacteria Mycobacterium tuberculosis (causes tuberculosis) Mycobacterium leprae (leprosy) Mycobacterium bovis (bovine tuberculosis) Mycobacterium avium complex (chronic lung disease; dissemina
  • FP wk3 Histopathology of Tissue Injury & Wound Healing - FCB — FCB_FP_Histopathology of Tissue Injury & Wound Healing_NK.pptx p.11: | ![Histology of lung granuloma with central necrosis in a patient with tuberculosis. Note the Langerhans-type giant cells (with many nuclei arranged in a horseshoe-like pattern at the edge of the ce

Q09: Where do students learn about pulmonary embolism?

Query pulmonary embolism · scope PCV AY25-26 · gold Pulmonary Vascular Disease · recall@10 1/1

MeSH expansion added: Embolus, Pulmonary Thromboembolisms, Pulmonary Thromboembolism, Pulmonary Embolisms, Embolisms

score course campus week event_title method title objective material top_file
2.48 PCV FCB 6 Pulmonary Vascular Disease - FCB Lecture 0.96 0.53 1 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25 Fixed.pdf
2.28 PCV AMC 6 Pulmonary Vascular Disease - AMC Lecture 0.81 0.53 0.94 Pulmonary Vascular Disease 2025.pptx
2.07 PCV FCB 1 Pulmonary + Systemic Circulation - FCB Lecture 0.96 0.69 0.43 FCB-PCV-Circulatory Physiology-FA25-AC.pptx
2.02 PCV AMC 1 Pulmonary + Systemic Circulation - AMC Lecture 0.91 0.69 0.42 Circulation talk 2025.pptx
2 PCV AMC 5 PCV Clinical Cases: Radiology, Malignancy, and Hemoptysis - AMC Case-Based Instruction/Learning 0 1 1 Clinical Cases - Radiology, malignancy, hemoptysis, immune Teachers Guide and post session distribution.docx
1.84 PCV FCB 1 Pulmonary Function Testing - FCB Lecture 0.96 0.48 0.4 1-00025-Pulmonary Function Tests_CONTENT_GCA_25.pdf
1.7 PCV AMC 5 Heart Failure & Cardiomyopathy - AMC Case-Based Instruction/Learning 0.52 0.32 0.85 Heart Failure and Cardiomyopathy - FINAL 2025.pptx
1.7 PCV AMC 5 Immunology: Autoimmune Lung Disease, Sinus Disease & Hemorrhage - AMC Large Group 0.67 0.62 0.41 PCV. Autoimmune Lung Disease 2025_before class_FINAL.pptx
1.65 PCV AMC 1 PCV Week 1: DOCS SPETA - AMC Small Group 0.67 0.59 0.39 1. DOCS Student Guide PCV Week 1 AY25-26.docx
1.32 PCV FCB 5 Pulmonary Considerations of Immunocompromised Patients - FCB Lecture 0.92 0 0.4 Pulmonary Infections in the Immunocompromised Host Dec 2025 FINAL.pptx
  • PCV wk5 PCV Clinical Cases: Radiology, Malignancy, and Hemoptysis - AMC — Clinical Cases - Radiology, malignancy, hemoptysis, immune Teachers Guide and post session distribution.docx p.9: | pulmonary embolism should be high on the differential particularly given this is a “can’t miss” diagnosis and the patient has risk factors (GI cancer). What is the next best study to determine his
  • PCV wk6 Pulmonary Vascular Disease - FCB — 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25.pdf p.11: | 1 2 Pulmonary embolism diagnosis
  • PCV wk Pulmonary Vascular Disease - FCB — 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25 Fixed.pdf p.11: | 1 2 Pulmonary embolism diagnosis

Q10: Where are the types of shock (cardiogenic, distributive, hypovolemic) taught?

Query shock cardiogenic distributive hypovolemic · scope PCV AY25-26 · gold Shock · recall@10 1/1

MeSH expansion added: Hypovolemias, Hypovolemic Shock, Hypovolemia, Cardiogenic Shock, Circulatory Failure, Circulatory Collapse, Hypovolemics

score course campus week event_title method title objective material top_file
2.32 PCV AMC 6 Shock - AMC Case-Based Instruction/Learning 0.88 0.71 0.73 FINAL Shock QUESTIONS for Release BEFORE session PCV 2025.pptx
1.71 PCV FCB 6 Shock - FCB Lecture 1 0.71 0 nan
1.31 PCV FCB 2 Overview of Dysrhythmias - FCB Lecture 0 1 0.31 2-00175-Abnormal Cardiac Electrophysiology_CONTENT_GCA_25.pdf
1.21 PCV AMC 2 Overview of Dysrhythmias - AMC Lecture 0 1 0.21 Overview of Dysrhytmias 2025 FINAL release before.pptx
1 PCV AMC 6 PCV Week 6: Chief Concern - AMC Lecture 0 0 1 Week 6 Chief Concern 2025 - FINAL.pptx
0.62 PCV FCB 2 Autonomic Regulation of the Cardiovascular System - FCB Lecture 0 0.46 0.16 2-00145-Autonomic CV Regulation_CONTENT_GCA_25.pdf
0.57 PCV AMC 3 Acute Coronary Syndromes - Diagnosis & Management - AMC Large Group 0 0 0.57 Acute Coronary Syndromes Part 2 Bricker - Complications and Management 2025.pptx
0.52 PCV AMC 2 PCV Anatomy Lab 7: Thorax & Airway - AMC Laboratory 0 0.38 0.14 DRAFT_before_PCV Wk2 Anatomy Lab #7_AY25-26.pptx
0.51 PCV FCB 2 PCV Anatomy Lab 7: Thorax & Airway - FCB Laboratory 0 0.38 0.13 11-10-25 FCB-PCV-Gross Anatomy Lab Thorax & Airway.pptx
0.46 PCV AMC 3 Pathology Lab: Pathology of Atherosclerosis, Ischemia & Infarction - AMC Small Group 0 0 0.46 Atherosclerosis, Ischemia and Infarction- DURING AND AFTER LAB.pptx
  • PCV wk6 PCV Week 6: Chief Concern - AMC — Week 6 Chief Concern 2025 - FINAL.pptx p.15: | # Recap Reduced contractility Reduced preload Reduced afterload Cardiogenic shock Hypovolemic shock Distributive shock
  • PCV wk6 Shock - AMC — FINAL Shock QUESTIONS for Release BEFORE session PCV 2025.pptx p.16: | # Types of Shock & Pathophysiology Picture 3 Distributive – Vasodilation (pipe failure) and leaky capillaries (filter failure) Septic Non-septic (ex. anaphylaxis, drug/toxin mediat
  • PCV wk6 Shock - AMC — FINAL Shock ANSWERS for Release After session PCV 2025.pptx p.16: | # Types of Shock & Pathophysiology Picture 3 Distributive – Vasodilation (pipe failure) and leaky capillaries (filter failure) Septic Non-septic (ex. anaphylaxis, drug/toxin mediat

Q11: Where is antibiotic stewardship addressed?

Query antibiotic stewardship · scope all courses AY25-26 · gold (none specified) · recall@10 10 hits

MeSH expansion added: Anti Bacterial Compounds, Anti Bacterial Agent, Bacteriocidal Agent, Antimicrobial Stewardship, Anti-Mycobacterial Agents, Anti-Bacterial Agents, Antibacterial Agents, Anti Bacterial Compound, Anti-Bacterial Compound, Bacteriocidal Agents, Antibiotics

score course campus week event_title method title objective material top_file
1.98 FP AMC 2 Bacterial Genetics & Clinical Microbiology - AMC Lecture 0.55 0.95 0.48 Micro3 - Bacterial Genetics and Clinical Microbiology updated.pptx
1.55 FP FCB 2 Intro to Antimicrobial Therapy: Antibiotics, Antivirals, and Antifungals - FCB Lecture 1 0 0.55 2-00200-Intro to Antimicrobial Therapy_CONTENT_GCA_25.pdf
1.47 FP AMC 2 Bacterial Structure, Function & Pathogenesis - AMC Lecture 0 1 0.47 Micro2 - Bacterial Structure-function-pathogenesis.pptx
1.41 FP FCB 2 Bacterial Genetics & Clinical Microbiology - FCB Lecture 0 0.95 0.46 Bacterial Genetics & Clinical Microbiology (posted).pptx
1.38 FP AMC 2 FP Week 2: Prework - AMC Directed Independent Learning 0.14 0.91 0.33 FP Micro1-Micro7 post class answers and rationale.docx
1.32 PCV FCB 4 Pediatrics: CF, Childhood Cough & Infections - FCB Lecture 0 0.91 0.41 4-00380-CF, Childhood Cough & Infections_CONTENT_GCA_25-26.pdf
1.3 PCV AMC 4 Pediatrics: CF, Childhood Cough & Infections - AMC Lecture 0 0.91 0.39 Pediatric Pulmonology 2025 FINAL.pptx
1.29 FP FCB 1 Pharmacology: Routes of Administration - FCB Lecture 0 0.81 0.48 1-00065-Routes of Administration_CONTENT_GCA_25.pdf
1.27 FP FCB 2 Bacterial Structure, Function & Pathogenesis - FCB Lecture 0 1 0.27 Bacterial Structure, Function, and Pathogenesis (posted).pptx
1.27 MSI AMC 4 General Dermatology - Rashes & Acne - AMC Lecture 0 0.91 0.36 FINAL_AFTER_Rashes and Acne_2_12_26.pptx
  • FP wk3 Clinical Applications of Antimicrobial Pharmacology-Cases - FCB — 3-00345-Antimicrobial Pharmacology Cases_GCA_CONTENT_25 WITH ANSWERS.pdf p.6: | C Case 2: Broad-spectrum use in sepsis without de-escalation A 50-year-old diabetic patient with cellulitis presents in septic shock. He is started on a third-generation cephalosporin, but no cultu
  • FP wk3 Clinical Applications of Antimicrobial Pharmacology-Cases - FCB — 3-00345-Antimicrobial Pharmacology Cases_GCA_CONTENT_25 NO ANSWERS.pdf p.5: | C Case 2: Broad-spectrum use in sepsis without de-escalation A 50-year-old diabetic patient with cellulitis presents in septic shock. He is started on a third-generation cephalosporin, but no cultu
  • FP wk2 Intro to Antimicrobial Therapy: Antibiotics, Antivirals, and Antifungals - FCB — 2-00200-Intro to Antimicrobial Therapy_CONTENT_GCA_25.pdf p.4: | P/R Preview / Review Common adverse effects Resistance mechanisms revisited • GI upset: Macrolides, β-lactams. • β-lactamases: Cleave β-lactam ring (e.g., Klebsiella). • Allergic reactions: Penicil

Q12: Where is cystic fibrosis covered across courses?

Query cystic fibrosis CFTR · scope all courses AY25-26 · gold Pediatrics: CF, Childhood Cough · recall@10 1/1

MeSH expansion added: Pancreas Fibrocystic Disease, Cystic Fibrosis of Pancreas, Fibrocystic Disease of Pancreas, Mucoviscidosis, Pancreas Fibrocystic Diseases, Fibroses, Cirrhosis, Pulmonary Cystic Fibrosis, Pancreatic Cystic Fibrosis

score course campus week event_title method title objective material top_file
1.87 PCV AMC 4 Pediatrics: CF, Childhood Cough & Infections - AMC Lecture 0 0.87 1 Pediatric Pulmonology 2025 FINAL.pptx
1.83 PCV FCB 4 Pediatrics: CF, Childhood Cough & Infections - FCB Lecture 0 0.87 0.96 4-00380-CF, Childhood Cough & Infections_CONTENT_GCA_25-26 Fixed.pdf
1.81 PCV AMC 4 PCV Week 4: Prework - AMC Directed Independent Learning 0 1 0.81 Cystic Fibrosis Prework - 2025 FINAL.docx
1.72 RU FCB 3 Developmental Cystic Diseases - FCB Lecture 1 0.34 0.38 3-00280-Developmental Cystic Diseases_CONTENT_GCA_26.pdf
1.5 RU AMC 3 Developmental Cystic Diseases - AMC Lecture 0.83 0.34 0.33 BEFORE session_Developmental cystic diseases_2026 with alt text done.pptx
1.36 PCV AMC 4 Pathology Lab: Histology & Pathology of Upper Respiratory Tract & Exposure-Related Lung Disease - AMC Laboratory 0 0.74 0.62 AFTER_Histology and Pathology of Upper Resp and Exposures answers.pdf
1.36 PCV FCB 4 Pathology Lab: Histology & Pathology of Upper Respiratory Tract & Exposure-Related Lung Disease - FCB Laboratory 0 0.74 0.62 4-00390-Pathology Upper Respiratory_CONTENT_GCA_25-26.pdf
1.2 RLC AMC 3 Prenatal Screening/Diagnosis - AMC Lecture 0 0.72 0.48 Prenatal Screning Diagnosis_OH edits 6.28.26.pptx
1 PCV FCB 4 PCV Week 4: Prework - FCB Directed Independent Learning 0 1 0 nan
0.95 PCV AMC 6 PCV Course Review - AMC Case-Based Instruction/Learning 0 0 0.95 PCV Course Review 2025.pptx
  • PCV wk4 Pediatrics: CF, Childhood Cough & Infections - AMC — Pediatric Pulmonology 2025 FINAL.pptx p.96: | # Take home points A common lethal genetic disease Cystic Fibrosis affects multiple organs Cystic fibrosis affects the airways and pulmonary parenchyma CFTR modulators have led to significant impro
  • PCV wk4 Pediatrics: CF, Childhood Cough & Infections - FCB — 4-00380-CF, Childhood Cough & Infections_CONTENT_GCA_25-26 Fixed.pdf p.80: | LEARNING OBJECTIVE HELPER 2.3 Pediatric Pulmonary Diseases - Risk Factors and Long-Term Sequelae: Asthma risk factors include a family history of atopy, early-life viral infections, and environment
  • PCV wk4 Pediatrics: CF, Childhood Cough & Infections - FCB — 4-00380-CF, Childhood Cough & Infections_CONTENT_GCA_25-26.pdf p.80: | LEARNING OBJECTIVE HELPER 2.3 Pediatric Pulmonary Diseases - Risk Factors and Long-Term Sequelae: Asthma risk factors include a family history of atopy, early-life viral infections, and environment

Q13: Where are congenital heart defects such as tetralogy of Fallot taught?

Query tetralogy of Fallot · scope PCV AY25-26 · gold Congenital Heart Disease, Heart Development · recall@10 2/2

MeSH expansion added: Fallot Tetralogy, Fallot’s Tetralogy, Fallots Tetralogy

score course campus week event_title method title objective material top_file
2.9 PCV AMC 2 Heart Development - AMC Lecture 1 1 0.9 PCV_CardiacEmbryo_Final with AnswerKey_release at 530pm_2025.pptx
1.94 PCV FCB 2 Heart Development - FCB Lecture 0 1 0.94 FCB-PCV-Heart Development-2025.pptx
1.9 PCV AMC 5 Congenital Heart Disease - AMC Lecture 0 1 0.9 FINAL_DURING CLASS_CONGENITAL HEART DISEASE_12.9.2025.pptx
1 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 0 1 Congenital disease prework PCV.docx
1 PCV FCB 5 Congenital Heart Disease - FCB Lecture 0 1 0 nan
0.65 PCV AMC 4 Infectious Heart Disease - AMC Lecture 0 0 0.65 Infectious Heart Disease_FINAL.pptx
  • PCV wk5 PCV Week 5: Prework - AMC — Congenital disease prework PCV.docx p.1: | Congenital Heart and Lung Disease Prework Review the following modules for familiarity with some of the congenital disease topics discussed this week. https://www.cincinnatichildrens.org/patients/c
  • PCV wk2 Heart Development - FCB — FCB-PCV-Heart Development-2025.pptx p.44: | # Tetralogy of Fallot Picture 5 https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02439-8 ![Image of the superior heart and great vessels from an infant which passed
  • PCV wk2 Heart Development - AMC — PCV_CardiacEmbryo_Final with AnswerKey_release at 530pm_2025.pptx p.27: | # 1. Which congenital heart variation is observed? Interventricular septal defect Interatrial septal defect Tetralogy of Fallot Patent truncus arteriosus Transposition of great vessels

Q14: Where is smoking cessation counseling taught?

Query smoking cessation · scope all courses AY25-26 · gold (none specified) · recall@10 10 hits

MeSH expansion added: Smoking Cessations, Quitting Smoking, Smoking Habit, Smoking Habits, Smoking Behavior, Giving Up Smoking, Stopping Smoking, Smoking Behaviors

score course campus week event_title method title objective material top_file
2.89 PCV AMC 5 Thoracic Malignancy - AMC Large Group 1 0.96 0.93 Thoracic Oncology Presentation_FINAL.pptx
1.54 PCV FCB 4 Pathology Lab: Histology & Pathology of Upper Respiratory Tract & Exposure-Related Lung Disease - FCB Laboratory 0 0.78 0.76 4-00390-Pathology Upper Respiratory_CONTENT_GCA_25-26 Fixed.pdf
1.39 PCV FCB 5 Thoracic Malignancy - FCB Lecture 0 0.96 0.43 FCB_PCV_Thoracic Malignancy_Slides.pptx
1.38 PCV FCB 5 Pathology Lab: Histology & Pathology of Thoracic Malignancy & Benign Nodular Lesions - FCB Laboratory 0 1 0.38 FCB_PCV_Histology & Pathology of Thoracic Malignancy & Benign Nodular Lesions_Worksheet Answers.docx
1.33 PCV AMC 5 Pathology Lab: Histology & Pathology of Thoracic Malignancy & Benign Nodular Lesions - AMC Case-Based Instruction/Learning 0 1 0.33 PROJECTED IN ROOM_Thoracic Malignancy and Benign Nodular Lesions facilitator presentation.pptx
1.21 PCV AMC 4 Pathology Lab: Histology & Pathology of Upper Respiratory Tract & Exposure-Related Lung Disease - AMC Laboratory 0 0.78 0.44 AFTER_Histology and Pathology of Upper Resp and Exposures answers.pdf
1.18 PCV FCB 4 Environment and Lung Disease - FCB Lecture 0 0.73 0.45 4-00410-Environmental Lung Disease_CONTENT_GCA_25-26.pdf
1.15 PCV AMC 4 Environment and Lung Disease - AMC Lecture 0 0.73 0.42 12.2.25 Environment and Lung Disease Lecture - FINAL.pptx
1 RLC AMC 3 RLC Week 3: H&S Large Group - AMC Lecture 0 0 1 RLC 10-3 MAKE UP Quiz with answers - Smoking.docx
0.98 FP FCB 1 Therapeutic Considerations - FCB Lecture 0 0 0.98 1-00070-Therapeutic Considerations_CONTENT_GCA_25.pdf
  • RLC wk3 RLC Week 3: H&S Large Group - AMC — RLC 10-3 MAKE UP Quiz with answers - Smoking.docx p.1: | Makeup Assignment: Systematic Reviews Week 10-3 - 2025 Question #: 1 This study was primarily designed to answer which one of the following research questions? (Use the PICO format as a guide.) A.
  • FP wk1 Therapeutic Considerations - FCB — 1-00070-Therapeutic Considerations_CONTENT_GCA_25.pdf p.47: | C Case 3: Theophylline and Smoking Cessation Question 1 - Clearance Change (LO3.2, LO4.1): How could smoking cessation affect theophylline metabolism? (Hint: Think about CYP enzyme expression) Ques
  • PCV wk5 Thoracic Malignancy - AMC — Thoracic Oncology Presentation_FINAL.pptx p.10: | # Smoking Cessation A picture containing bird Description automatically generated More smoking  Higher lung cancer risk Quitting smoking reduces lung cancer risk ![A cl

Q15: Where are social determinants of cardiovascular health discussed?

Query social determinants cardiovascular disease · scope PCV AY25-26 · gold H&S · recall@10 0/1 · missed H&S

MeSH expansion added: Adverse Cardiac Event, Adverse Cardiac Events, Diseases, Major Adverse Cardiac Events, Cardiovascular Diseases, Cardiac Event, Cardiac Events

score course campus week event_title method title objective material top_file
2.38 PCV AMC 3 Ischemia, Angina & Claudication - AMC Case-Based Instruction/Learning 1 1 0.38 M1 Event material for ischemia, angina, claudication 2025 FINAL.pptx
1.81 PCV FCB 2 Autonomic Regulation of the Cardiovascular System - FCB Lecture 0.8 0.54 0.48 2-00145-Autonomic CV Regulation_CONTENT_GCA_25.pdf
1.7 PCV AMC 1 PCV Week 1: DOCS SPETA - AMC Small Group 0.58 0.68 0.43 1. DOCS Student Guide PCV Week 1 AY25-26.docx
1.66 PCV AMC 3 Cardiovascular Ultrasound - AMC Laboratory 0.69 0.61 0.36 Thorax and Heart Ultrasound Session Learning Objectives 25.docx
1.63 PCV FCB 5 Immunology: Autoimmune Lung Disease, Sinus Disease & Hemorrhage - FCB Lecture 0.56 0.46 0.62 5-00520-Autoimmune Lung, Sinus & Hemorrhage_CONTENT_GCA_25-26.pdf
1.6 PCV FCB 3 Atherosclerosis, Lipids & Antilipemic Pharmacology - FCB Lecture 0 0.6 1 3-00270-Atherosclerosis & Antilipemics_CONTENT_GCA_25.pdf
1.59 PCV AMC 2 Overview of Obstructive Lung Disease - AMC Lecture 0.53 0.46 0.6 Overview of Obstructive Lung Disease 2025 - FINAL.pptx
1.57 PCV FCB 6 Pulmonary Vascular Disease - FCB Lecture 0.51 0.43 0.62 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25 Fixed.pdf
1.57 PCV AMC 5 Immunology: Autoimmune Lung Disease, Sinus Disease & Hemorrhage - AMC Large Group 0.56 0.46 0.55 PCV. Autoimmune Lung Disease 2025_before class_FINAL.pptx
1.56 PCV FCB 2 Overview of Obstructive Lung Disease - FCB Lecture 0.49 0.46 0.62 2-00140-Obstructive Lung Disease_CONTENT_GCA_25-26.pdf
  • PCV wk3 Atherosclerosis, Lipids & Antilipemic Pharmacology - FCB — 3-00270-Atherosclerosis & Antilipemics_CONTENT_GCA_25.pdf p.64: | C Case 8: Health inequities & atherosclerosis A 48-year-old factory worker with poorly controlled hypertension and high LDL cholesterol presents with angina. He reports limited access to healthy fo
  • PCV wk4 Pediatrics: CF, Childhood Cough & Infections - AMC — Pediatric Pulmonology 2025 FINAL.pptx p.76: | Picture 2 FYI # National Academy of Medicine Social Determinants of Health 101 for Health care: Five Plus Five https://nam.edu/social-determinants-of-health-101-for-health-care-fiv
  • PCV wk3 Atherosclerosis, Lipids & Antilipemic Pharmacology - AMC — FINAL 2025 Lipids and Anti-lipidemic Pharmacology​ 2024.pptx p.25: | # 4 Statin Benefit Groups #2: Severe hypercholesterolemia – LDL-C ≥190 mg/dL without secondary cause #1: Secondary atherosclerotic cardiovascular disease (ASCVD) prevention #3: Primary Prevention –

Q16: Where is point-of-care cardiac ultrasound taught?

Query cardiac ultrasound echocardiography · scope PCV AY25-26 · gold Cardiovascular Ultrasound, DOCS US · recall@10 2/2

MeSH expansion added: Two Dimensional Echocardiography, 2-D Echocardiography, Transthoracic Echocardiography, Cross Sectional Echocardiography, Two-Dimensional Echocardiography, Cross-Sectional Echocardiography, Contrast Echocardiography, M Mode Echocardiography, M-Mode Echocardiography, 2D Echocardiography, 2 D Echocardiography

score course campus week event_title method title objective material top_file
2.25 PCV AMC 1 The Cardiac Cycle - AMC Lecture 0.61 0.64 1 Cardiac Cycle 2025 FINAL.pptx
2.16 PCV AMC 1 Action Potentials and Conduction - AMC Lecture 0.52 0.64 1 APs and Conduction 2025.pptx
2.12 PCV AMC 3 Cardiovascular Ultrasound - AMC Laboratory 0.79 0.88 0.45 PCV pre-work 25.docx
1.89 PCV FCB 1 Cardiac and Smooth Muscle Physiology - FCB Lecture 0.71 0.74 0.44 1-00055-Cardiac & Smooth Muscle Physiology_CONTENT_GCA_25.pdf
1.88 PCV FCB 3 Cardiovascular Ultrasound - FCB Laboratory 1 0.88 0 nan
1.69 PCV AMC 4 PCV Week 4: DOCS US - AMC Small Group 0.71 0.97 0 nan
1.67 PCV FCB 1 The Cardiac Cycle - FCB Lecture 0.78 0.64 0.26 FCB-PCV-Cardiac cycle-FA25-AC.pptx
1.66 PCV AMC 1 Cardiac and Smooth Muscle Physiology - AMC Lecture 0.65 0.74 0.27 FINAL Cardiac and Smooth Muscle 2025 - FINAL.pptx
1.53 PCV AMC 3 Pleural & Pericardial Disease - AMC Lecture 0.58 0.67 0.28 Pleural Disease Trek Curriculum 2025 - FINAL.pptx
1.48 PCV FCB 1 Cardiac Conduction & ECG Intro - FCB Lecture 0.71 0.54 0.22 1-00060-Cardiac Conduction & ECG Intro_CONTENT_GCA_25.pdf
  • PCV wk1 Action Potentials and Conduction - AMC — APs and Conduction 2025.pptx p.3: | Cardiac Ultrasound (Echocardiography) Made Easy: Step-By-Step Guide - POCUS 101
  • PCV wk1 The Cardiac Cycle - AMC — Cardiac Cycle 2025 FINAL.pptx p.23: | Cardiac Ultrasound (Echocardiography) Made Easy: Step-By-Step Guide - POCUS 101
  • PCV wk3 Ischemia, Angina & Claudication - FCB — 3-00265-Ischemia, Angina & Claudication_CONTENT_GCA_25.pdf p.47: | Q’s Question A 63-year-old patient with hypertension and diabetes presents with calf pain after walking one block that resolves with rest. Physical examination shows diminished femoral and pedal pu

Q17: Where is the mechanism of action of statins taught?

Query statin HMG-CoA reductase · scope all courses AY25-26 · gold Atherosclerosis, Lipids & Antilipemic · recall@10 1/1

MeSH expansion added: Hydroxymethylglutaryl CoA Reductase Inhibitors, Hydroxymethylglutaryl CoA Reductases, Statins, 3 Hydroxy 3 methylglutaryl CoA Reductase, Oxidoreductase, Hydroxymethylglutaryl-CoA Inhibitors, HMG-CoA Reductase Inhibitor, CoASH, Hydroxymethylglutaryl CoA Reductase, Hydroxymethylglutaryl-CoA Reductase Inhibitor, HMG-CoA Statins

score course campus week event_title method title objective material top_file
2 PCV AMC 3 Atherosclerosis, Lipids & Antilipemic Pharmacology - AMC Large Group 0 1 1 FINAL 2025 Lipids and Anti-lipidemic Pharmacology​ 2024.pptx
1.8 PCV FCB 3 Atherosclerosis, Lipids & Antilipemic Pharmacology - FCB Lecture 0 1 0.8 3-00270-Atherosclerosis & Antilipemics_CONTENT_GCA_25.pdf
1.4 PCV AMC 3 PCV Week 3: Prework - AMC Directed Independent Learning 0 0.8 0.6 0 - Lipids Pre-Work Handout_Trek 2022.docx
0.8 PCV FCB 3 PCV Week 3: Prework - FCB Directed Independent Learning 0 0.8 0 nan
0.5 PCV FCB 3 Ischemia, Angina & Claudication - FCB Lecture 0 0 0.5 3-00265-Ischemia, Angina & Claudication_CONTENT_GCA_25.pdf
0.47 EM nan 1 Pathophysiology of Type 1 Diabetes Lecture 0 0 0.47 PathophysT1DM2026INSTRUCTORDONOTPOSTFORSTUDENTSfinal.pptx
0.29 FP FCB 4 Normal and Cancer Cell Metabolism - FCB Lecture 0 0 0.29 FCB_FP_Normal and Cancer Metabolism.pptx
0.28 FP AMC 4 Normal and Cancer Cell Metabolism - AMC Lecture 0 0 0.28 Normal and Cancer Cell Metabolism_Slater2025.pptx
0.22 RLC FCB 1 Differences in Sexual Development - FCB Lecture 0 0 0.22 FCB-RLC-Differences in Sexual Development-Slides.pptx
0.22 RLC AMC 1 Normal Embryology: Development & Differentiation of the Reproductive System - AMC Lecture 0 0 0.22 Trek Repro Life Cycle Development Differentiation of Reproductive System DRAFT MAY 2026.reviewed.pptx
  • PCV wk3 Atherosclerosis, Lipids & Antilipemic Pharmacology - AMC — FINAL 2025 Lipids and Anti-lipidemic Pharmacology​ 2024.pptx p.30: | # Statins = HMG CoA Reductase Inhibitors Mechanism of Action: Inhibit HMG CoA reductase Decrease hepatic pool of free cholesterol Increase expression of LDL receptors on cell membranes Increase cat
  • PCV wk3 Atherosclerosis, Lipids & Antilipemic Pharmacology - FCB — 3-00270-Atherosclerosis & Antilipemics_CONTENT_GCA_25.pdf p.25: | 1 2 4 Statins: HMG-CoA inhibitors
  • PCV wk3 PCV Week 3: Prework - AMC — 0 - Lipids Pre-Work Handout_Trek 2022.docx p.9: | tropical vegetable oils and nuts; and limits intake of sweets, sugar-sweetened beverages, processed foods and red meats. Also recommended is for adults to engage in aerobic physical activity incorp

Q18: Where is the systematic approach to reading a chest X-ray taught?

Query chest radiograph systematic approach · scope PCV AY25-26 · gold Introduction to Chest Radiography · recall@10 1/1

MeSH expansion added: Thorax, Thoraces, Chests, Thorace

score course campus week event_title method title objective material top_file
3 PCV AMC 2 Introduction to Chest Radiography - AMC Lecture 1 1 1 IntroChestXRAY 25-26 - FINAL.pptx
2.36 PCV FCB 2 Introduction to Chest Radiography - FCB Lecture 0.36 1 1 IntroChestXRAY 25-26 - FINAL.pptx
1.48 PCV AMC 3 PCV Week 3: Chief Concern - AMC Lecture 0.43 0.5 0.55 Week 3 Chief Concern - 2025 - FINAL - Chest Pain Release AFTER.pptx
1.31 PCV AMC 2 PCV Week 2: Prework - AMC Directed Independent Learning 0 0.38 0.93 Fundamentals of Chest Radiography.pdf
1.24 PCV AMC 5 PCV Clinical Cases: Radiology, Malignancy, and Hemoptysis - AMC Case-Based Instruction/Learning 0.27 0.29 0.68 Clinical Cases - Radiology, malignancy, hemoptysis, immune Teachers Guide and post session distribution.docx
1.15 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0.3 0.36 0.49 PCV CT Chest Prework w audio.pptx
1.09 PCV FCB 3 PCV Week 3: Chief Concern - FCB Large Group 0 0.5 0.59 Chief Concern - FINAL PCV week 3 Faculty version - delayed release.pptx
0.87 PCV AMC 3 ECG Cases: Chest Pain and Ischemia - AMC Case-Based Instruction/Learning 0.31 0.23 0.33 Ischemia ECG cases with answers - FINAL, release AFTER1.pptx
0.86 PCV AMC 4 PCV Week 4: Chief Concern - AMC Lecture 0.18 0.21 0.47 Week 4 Chief Concern 2025 - FINAL.pptx
0.83 PCV FCB 5 Pulmonary Considerations of Immunocompromised Patients - FCB Lecture 0 0.24 0.59 Pulmonary Infections in the Immunocompromised Host Dec 2025 FINAL.pptx
  • PCV wk2 Introduction to Chest Radiography - AMC — IntroChestXRAY 25-26 - FINAL.pptx p.3: | # Learning Objectives Employ a systematic search pattern for interpreting chest x-rays; “how to read a chest radiograph.” Understand penetration, inflation, and rotation on chest X-rays and how the
  • PCV wk2 PCV Week 2: Prework - AMC — Fundamentals of Chest Radiography.pdf p.10: | Radiography version 04.21.18 Lavelle A systematic approach A systematic approach to the interpretation of chest radiography findings ensures that we don’t forget anything in the interpretation. One
  • PCV wk5 PCV Clinical Cases: Radiology, Malignancy, and Hemoptysis - AMC — Clinical Cases - Radiology, malignancy, hemoptysis, immune Teachers Guide and post session distribution.docx p.11: | FH: Adopted What is your initial differential diagnosis of his hemoptysis? See Algorithm above What testing would you like to evaluate the cause of his hemoptysis? CT of the chest would be the test

Q19: Where is anticoagulation first introduced and where is it revisited?

Query anticoagulant heparin warfarin · scope all courses AY25-26 · gold Anticoagulants, Antiplatelets · recall@10 1/1

MeSH expansion added: Anticoagulant Drugs, Warfarin Sodium, Tedicumar, Liquaemin, Gen-Warfarin, Aldocumar, Anticoagulant Drug, Anticoagulation Agents, Anticoagulant Agents, Heparin Sodium, 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one

score course campus week event_title method title objective material top_file
2.92 PCV AMC 3 Anticoagulants, Antiplatelets & Thrombolytics - AMC Lecture 1 0.92 1 Zuckerman Final AFTER Anticoagulants Antiplateletes Thrombolytics v10032025.pptx
2.74 PCV FCB 3 Anticoagulants, Antiplatelets & Thrombolytics - FCB Lecture 0.99 0.92 0.83 3-00290-Anticoagulants, Antiplatelets_CONTENT_GCA_25.pdf
1.87 FP FCB 1 Case-Based Review: Pharmacogenetics - FCB Case-Based Instruction/Learning 0 1 0.87 1-00085-Case-Based Pharmacogenetics_CONTENT_GCA_25.pdf
1.71 FP AMC 1 Case-Based Review: Pharmacogenetics - AMC Lecture 0 1 0.71 Draft_Before_Pharmacogenomics_Zuckerman_06132025.pptx
0.88 PCV AMC 3 Ischemia, Angina & Claudication - AMC Case-Based Instruction/Learning 0 0 0.88 M1 Event material for ischemia, angina, claudication 2025 FINAL.pptx
0.71 PCV AMC 6 Pulmonary Vascular Disease - AMC Lecture 0 0 0.71 Pulmonary Vascular Disease 2025.pptx
0.65 PCV AMC 3 ECG Cases: Chest Pain and Ischemia - AMC Case-Based Instruction/Learning 0 0 0.65 Ischemia ECG cases student - FINAL, release BEFORE1.pptx
0.65 PCV AMC 3 Acute Coronary Syndromes - Diagnosis & Management - AMC Large Group 0 0 0.65 Acute Coronary Syndromes Part 2 Bricker - Complications and Management 2025.pptx
0.59 PCV FCB 3 Ischemia, Angina & Claudication - FCB Lecture 0 0 0.59 3-00265-Ischemia, Angina & Claudication_CONTENT_GCA_25.pdf
0.53 RU AMC 4 Renal Failure Pharmacology - AMC Lecture 0 0 0.53 Final_Before_RenalFailurePharmZuckerman_Halmo v12052025.pptx
  • PCV wk3 Anticoagulants, Antiplatelets & Thrombolytics - AMC — Zuckerman Final AFTER Anticoagulants Antiplateletes Thrombolytics v10032025.pptx p.39: | # 38 year old develops right arm DVT. Appropriate therapy includes Heating pad with PO aspirin IV Heparin PO Warfarin with IV heparin bridge PO Warfarin with SC enoxaparin bridge Rivaroxaban
  • PCV wk3 Ischemia, Angina & Claudication - AMC — M1 Event material for ischemia, angina, claudication 2025 FINAL.pptx p.54: | # Anti-thrombotic Medical Targets Picture 3 Anti-platelet agents (aspirin, P2Y12 inhibitors, GP 2b/3a inhibitors) Anticoagulants (warfarin, unfractionated heparin, LMWH, direct thr
  • FP wk1 Case-Based Review: Pharmacogenetics - FCB — 1-00085-Case-Based Pharmacogenetics_CONTENT_GCA_25.pdf p.11: | 3 Case: polymorphisms & warfarin • A 28-year-old healthy individual presents with pain and swelling in the left lower leg. Ultrasound confirms a deep vein thrombosis, and the patient is admitted fo

Q20: How does asthma coverage progress through PCV (immunology, pharmacology, cases)?

Query asthma · scope PCV AY25-26 · gold Asthma, Allergens, Lower Airway Pharmacology, Clinical Cases: Asthma & COPD, Obstructive Lung Disease · recall@10 4/4

MeSH expansion added: Bronchial Asthma, Asthmas

score course campus week event_title method title objective material top_file
2.83 PCV AMC 2 Immunology: Asthma, Allergens & Anaphylaxis - AMC Case-Based Instruction/Learning 1 0.84 0.99 PCV. Asthma, Allergens & Anaphylaxis 2025_before class_FINAL.pptx
2.73 PCV FCB 2 Immunology: Asthma, Allergens & Anaphylaxis - FCB Lecture 0.91 0.84 0.99 2-00150-Asthma, Allergens & Anaphylaxis_CONTENT_GCA_25-26.pdf
2.44 PCV AMC 2 Overview of Obstructive Lung Disease - AMC Lecture 0.73 0.79 0.92 Overview of Obstructive Lung Disease 2025 - FINAL.pptx
2.38 PCV AMC 2 PCV Clinical Cases: Asthma & COPD - AMC Case-Based Instruction/Learning 0.68 0.75 0.94 Clinical Cases Asthma and COPD - Student version for release before.pptx
1.89 PCV AMC 2 PCV Week 2: Prework - AMC Directed Independent Learning 0 1 0.89 STUDENT GUIDE. PCV Immunology. Allergens, Asthma & Anaphylaxis.pdf
1.74 PCV FCB 2 Lower Airway Pharmacology - FCB Lecture 0 0.79 0.95 2-00155-Lower Airway Pharmacology_CONTENT_GCA_25.pdf
1.72 PCV AMC 2 Lower Airway Pharmacology - AMC Large Group 0 0.79 0.93 Zuckerman Final AFTER PCV Lower Airway Pharm v10032025.pptx
1.66 PCV FCB 2 Overview of Obstructive Lung Disease - FCB Lecture 0 0.79 0.87 2-00140-Obstructive Lung Disease_CONTENT_GCA_25-26.pdf
1.64 PCV FCB 1 Pulmonary Function Testing - FCB Lecture 0 0.72 0.93 1-00025-Pulmonary Function Tests_CONTENT_GCA_25.pdf
1.63 PCV FCB 2 PCV Clinical Cases: Asthma & COPD - FCB Small Group 0.87 0.75 0 nan
  • PCV wk4 PCV Week 4: VISTA - AMC — Health Equity PCV Vista 2025.pptx p.22: | # Key Data Points on Asthma Mortality | Factor | FINDINGS | | — | — | | Age | Adults >6x more likely than children to die; highest among age ≥65 | | Gender | Females have higher death rates tha
  • PCV wk2 Immunology: Asthma, Allergens & Anaphylaxis - AMC — PCV. Asthma, Allergens & Anaphylaxis 2025_before class_FINAL.pptx p.2: | # Learning Objectives. Immunology: Asthma, Allergens & Irritants PRE-WORK Define allergen Define asthma IN-CLASS Explain airway inflammation in asthma and allergy Describe the current understanding
  • PCV wk2 Immunology: Asthma, Allergens & Anaphylaxis - FCB — 2-00150-Asthma, Allergens & Anaphylaxis_CONTENT_GCA_25-26.pdf p.29: | Q’s Question A 46-year-old individual with a history of severe persistent asthma presents for evaluation of poorly controlled symptoms despite high-dose inhaled corticosteroids and long-acting β₂-a

Q21: How much scheduled time does PCV devote to heart failure?

Query heart failure · scope PCV AY25-26 · gold Heart Failure & Cardiomyopathy, Principles of Heart Failure Treatment, Pathology Lab: Heart Failure, Heart and Respiratory Failure · recall@10 4/4

MeSH expansion added: Right Sided Heart Failure, Congestive Heart Failure, Left-Sided Heart Failure, Cardiac Failure, Left Sided Heart Failure, Heart Decompensation, Myocardial Failure, Right-Sided Heart Failure, Hearts

score course campus week event_title method title objective material top_file
2.81 PCV FCB 5 Heart Failure & Cardiomyopathy - FCB Lecture 1 0.81 1 FCB-PCV-Heart Failure and Cardiomyopathy-FA25-AC-FINAL.pptx
2.7 PCV FCB 6 Principles of Heart Failure Treatment - FCB Lecture 0.96 0.85 0.89 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf
2.61 PCV AMC 6 Principles of Heart Failure Treatment - AMC Lecture 0.77 0.85 0.98 Principles of Heart Failure Treatment - 2025 FINAL.pptx
2.54 PCV AMC 5 Heart Failure & Cardiomyopathy - AMC Case-Based Instruction/Learning 0.8 0.81 0.93 Heart Failure and Cardiomyopathy - FINAL 2025.pptx
2.48 PCV AMC 6 Pathology Lab: Heart Failure and Cardiomyopathy - AMC Laboratory 0.79 0.71 0.97 AFTER_Heart Failure and Cardiomyopathy answers.pdf
2.47 PCV FCB 6 Pathology Lab: Heart Failure and Cardiomyopathy - FCB Laboratory 0.92 0.71 0.83 6-00645-Cardiomyopathy Pathology_CONTENT_GCA_25 Fixed.pdf
2.46 PCV AMC 6 PCV Clinical Cases: Heart and Respiratory Failure - AMC Case-Based Instruction/Learning 0.89 0.66 0.91 FINAL PCV Cases Heart and Resp Failure Week 6 2025 - with answers, release AFTER.pptx
1.96 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 1 0.96 PCV Heart failure prework w audio.pptx
1.69 PCV AMC 6 PCV Week 6: Prework - AMC Directed Independent Learning 0 0.81 0.88 PCV Heart failure treatments prework slides.pptx
1.64 PCV AMC 4 Valvular Heart Disease - AMC Case-Based Instruction/Learning 0.52 0.43 0.7 Valvular Heart Disease_2025.pptx
  • PCV wk5 Heart Failure & Cardiomyopathy - FCB — FCB-PCV-Heart Failure and Cardiomyopathy-FA25-AC-FINAL.pptx p.33: | # Consequences of Right vs. Left sided Heart Failure LO 1: LO 2: ![Difference Between CHF Left and CHF Right | Difference Between in 2021 | Left sided heart failur
  • PCV wk6 Principles of Heart Failure Treatment - AMC — Principles of Heart Failure Treatment - 2025 FINAL.pptx p.4: | # Goals of therapy: Live longer, feel better Treatment is differs based on type of heart failure and underlying cause: Heart failure with reduced ejection fraction (HFrEF, systolic heart failure) H
  • PCV wk6 Pathology Lab: Heart Failure and Cardiomyopathy - AMC — AFTER_Heart Failure and Cardiomyopathy answers.pdf p.49: | Q3. Which clinical classification would you give his heart failure? A. Acutely decompensated heart failure B. De novo acute heart failure C. Chronic heart failure Q4. What supports this diagnosis?

Q22: Which PCV objectives address physical examination skills?

Query physical examination · scope PCV AY25-26 · gold DOCS · recall@10 1/1

MeSH expansion added: Physical Exams, Physical Examinations, Physical Examinations and Diagnoses

score course campus week event_title method title objective material top_file
1.6 PCV AMC 1 PCV Week 1: Chief Concern - AMC Lecture 0.75 0.37 0.48 Chief Concern Week 1, Athlete Physical - 2025 Final.pptx
1.48 PCV AMC 6 PCV Week 6: DOCS Small Group - AMC Small Group 0.48 1 0 nan
1.45 PCV AMC 1 The Cardiac Cycle - AMC Lecture 0.65 0.34 0.46 Cardiac Cycle 2025 FINAL.pptx
1.42 PCV AMC 1 PCV Week 1: DOCS SPETA - AMC Small Group 0.82 0 0.6 1. DOCS Student Guide PCV Week 1 AY25-26.docx
1.1 PCV AMC 6 Pulmonary Cases - AMC Large Group 0.75 0.34 0 nan
1.1 PCV AMC 6 CV Cases - AMC Large Group 0.75 0.34 0 nan
1.04 PCV FCB 1 The Cardiac Cycle - FCB Lecture 0 0.34 0.7 FCB-PCV-Cardiac cycle-FA25-AC.pptx
1 PCV AMC 4 Valvular Heart Disease - AMC Case-Based Instruction/Learning 0 0 1 Valvular Heart Disease_2025.pptx
1 PCV FCB 6 PCV Week 6: DOCS Small Group - FCB Small Group 0 1 0 nan
1 PCV FCB 6 PCV Week 6: DOCS Optional Physical Exam Practice - FCB Other 1 0 0 nan
  • PCV wk4 Valvular Heart Disease - AMC — Valvular Heart Disease_2025.pptx p.29: | # Case Five A 72-year-old person presents for an annual physical. On physical exam you notice prominent v waves when you examine the jugular vein, a pulsatile liver, and 2+ pitting edema in the low
  • PCV wk3 Pleural & Pericardial Disease - AMC — Pleural Disease Trek Curriculum 2025 - FINAL.pptx p.6: | # Diagnostic Evaluation: Clinical History & Exam History: Dyspnea Pleuritic chest pain Cough Physical Exam: Decreased breath sounds Dullness to percussion Decreased tactile vocal fremitus on examin
  • PCV wk5 Pulmonary Considerations of Immunocompromised Patients - AMC — Pulmonary Considerations in Immunocompromised_12092025_final.pptx p.19: | Picture 3 # Pneumocystis Clinical manifestations (cont.) Physical examination: Tachycardia, tachypnea, fever Accessory muscle use during inspiration Often normal chest auscultation

Q23: What objectives exist on valvular heart disease and at what Bloom levels?

Query valvular stenosis regurgitation · scope PCV AY25-26 · gold Valvular Heart Disease, Pathology of Valvular Heart Disease, Vessel & Valve · recall@10 3/3

MeSH expansion added: Pathological Constriction, Pathologic Constrictions, Strictures, Stenoses, Stricture, Pathologic Constriction

score course campus week event_title method title objective material top_file
2.82 PCV AMC 4 Valvular Heart Disease - AMC Case-Based Instruction/Learning 0.82 1 1 Valvular Heart Disease_2025.pptx
2.45 PCV AMC 5 Pathology Lab: Histology & Pathology of Valvular Heart Disease - AMC Laboratory 0.66 0.92 0.88 Valvular Heart Disease- DURING AND AFTER LAB.pptx
2.43 PCV FCB 5 Pathology Lab: Histology & Pathology of Valvular Heart Disease - FCB Laboratory 0.85 0.92 0.67 5-00525-Histology & Pathology of Valvular Heart Disease _CONTENT_GCA_25-26.pdf
2.17 PCV AMC 4 PCV Clinical Cases: Vessel & Valve Diseases - AMC Case-Based Instruction/Learning 0.68 0.99 0.5 Vessel and Valve cases - Bricker - release POST - 2025.pptx
2 PCV FCB 4 Valvular Heart Disease - FCB Lecture 1 1 0 nan
0.99 PCV FCB 4 PCV Clinical Cases: Vessel & Valve Diseases - FCB Lecture 0 0.99 0 nan
0.67 PCV AMC 3 Diseases of the Aorta & Large Vessels - AMC Lecture 0 0 0.67 1.0_Final_During_ Diseases_of_Aorta_11_18_25.pptx
0.6 PCV AMC 4 Infectious Heart Disease - AMC Lecture 0 0 0.6 Infectious Heart Disease_FINAL.pptx
0.6 PCV FCB 4 Infectious Heart Disease - FCB Lecture 0 0 0.6 Infectious Heart Disease FINAL Dec 3 2025.pptx
0.53 PCV AMC 5 Congenital Heart Disease - AMC Lecture 0 0 0.53 How to Describe a Murmur handout.pdf
  • PCV wk4 Valvular Heart Disease - AMC — Valvular Heart Disease_2025.pptx p.7: | # ARS What valvular problem do they have? Tricuspid regurgitation Aortic stenosis Mitral Stenosis Mitral regurgitation
  • PCV wk5 Pathology Lab: Histology & Pathology of Valvular Heart Disease - AMC — Valvular Heart Disease- BEFORE LAB FOR STUDENTS.pptx p.14: | # Q6. Please list some common causes of valvular diseases in each category. ![Table of common causes of acquired valvular disease. Common ones listed: Mitral stenosis: postinflammatory scarring Aor
  • PCV wk5 Pathology Lab: Histology & Pathology of Valvular Heart Disease - AMC — Valvular Heart Disease- DURING AND AFTER LAB.pptx p.21: | # Q6. Please list some common causes of valvular diseases in each category. ![Table of common causes of acquired valvular disease. Common ones listed: Mitral stenosis: postinflammatory scarring Aor

Q25: Which objectives mention heart murmurs, and do those sessions’ slides cover murmurs?

Query murmur · scope PCV AY25-26 · gold Valvular Heart Disease, Cardiac Cycle · recall@10 1/2 · missed Cardiac Cycle

score course campus week event_title method title objective material top_file
2 PCV AMC 5 PCV Week 5: DOCS Large Group - AMC Large Group 1 1 0 nan
1 PCV AMC 5 Congenital Heart Disease - AMC Lecture 0 0 1 FINAL_DURING CLASS_CONGENITAL HEART DISEASE_12.9.2025.pptx
1 PCV FCB 5 PCV Week 5: DOCS Large Group - FCB Large Group 0 1 0 nan
0.99 PCV AMC 1 PCV Week 1: Chief Concern - AMC Lecture 0 0 0.99 Chief Concern Week 1, Athlete Physical - 2025 Final.pptx
0.99 PCV AMC 2 PCV Week 2: H&S Large Group - AMC Large Group 0 0 0.99 PCV 4-2 EBM Diagnostic Studies PPT.pdf
0.95 PCV AMC 5 Pathology Lab: Histology & Pathology of Valvular Heart Disease - AMC Laboratory 0 0 0.95 Valvular Heart Disease- BEFORE LAB FOR STUDENTS.pptx
0.9 PCV AMC 4 Valvular Heart Disease - AMC Case-Based Instruction/Learning 0 0 0.9 Valvular Heart Disease_2025.pptx
0.79 PCV AMC 3 ECG Cases: Chest Pain and Ischemia - AMC Case-Based Instruction/Learning 0 0 0.79 Ischemia ECG cases student - FINAL, release BEFORE1.pptx
0.77 PCV AMC 6 PCV Course Review - AMC Case-Based Instruction/Learning 0 0 0.77 PCV Course Review 2025.pptx
0.71 PCV AMC 6 Pulmonary Vascular Disease - AMC Lecture 0 0 0.71 Pulmonary Vascular Disease 2025.pptx
  • PCV wk5 Congenital Heart Disease - AMC — FINAL_DURING CLASS_CONGENITAL HEART DISEASE_12.9.2025.pptx p.18: | Murmur A diagram of an asd Description automatically generated Secundum ASD The murmur in an ASD is not generated from blood crossing the hole What generates the m
  • PCV wk1 PCV Week 1: Chief Concern - AMC — Chief Concern Week 1, Athlete Physical - 2025 Final.pptx p.9: | # You hear something abnormal (murmur) . . . . Is it systolic or diastolic? Systolic murmurs: occur between S1 & S2 If it is a systolic, where could the murmur be originating? ![object 15](object15
  • PCV wk2 PCV Week 2: H&S Large Group - AMC — PCV 4-2 EBM Diagnostic Studies PPT.pdf p.15: | What is the effect of “non-blinding” on estimates of accuracy of a diagnostic test? Tests where subjective judgements are required seem better than they are. That is, the test under consideration a

Q26: Which courses teach the renin-angiotensin-aldosterone system?

Query renin angiotensin aldosterone · scope all courses AY25-26 · gold (none specified) · recall@10 10 hits

MeSH expansion added: Angiotensin-Forming Enzyme, Preprorenin, Pre Prorenin, Angiotensins, Angiotensin Forming Enzyme, Inactive Renin, Pre-Prorenin, Prorenin, Big Renin

score course campus week event_title method title objective material top_file
1.9 RU AMC 2 Extracellular Na+ & H2O - AMC Lecture 0 0.91 0.99 Regulation of ECF Na and H2O_1.20.26.pptx
1.88 EM AMC 2 Review of Endocrine Regulation of Kidneys - AMC Lecture 0 1 0.88 Endocrine regulation of kidneys 2026BEFORECLASS.pptx
1.78 EM FCB 2 Review of Endocrine Regulation of Kidneys - FCB Lecture 0 1 0.78 2-20260526_1000-Renal Endocrine Review_CONTENT_GCA_26.pdf
1.76 RU FCB 2 Extracellular Na+ & H2O - FCB Lecture 0 0.91 0.85 2-00155-Extracellular Na+ & H2O_GCA_CONTENT_26.pdf
1.73 PCV AMC 6 PCV Week 6: Prework - AMC Directed Independent Learning 0 0.88 0.86 PCV Heart failure treatments prework slides.pptx
1.57 RU AMC 1 Overview of Renal Physiology - AMC Lecture 0 0.72 0.86 Renal Physiology REC 2026.pptx
1.51 RU FCB 1 Overview of Renal Physiology - FCB Lecture 0 0.72 0.79 1-00020-Course Intro & Overview of Renal Physiology_GCA_CONTENT_26.pdf
1.22 PCV AMC 6 Principles of Heart Failure Treatment - AMC Lecture 0 0.47 0.76 Principles of Heart Failure Treatment - 2025 FINAL.pptx
1.2 EM AMC 4 Adrenal Hypofunction & Hyperfunction - AMC Lecture 0 0.32 0.89 Adrenal Hypo- & HyperfunctionBEFORECLASSFINAL.pptx
1.17 EM FCB 4 Adrenal Hypofunction & Hyperfunction - FCB Lecture 0 0.32 0.85 FCB_EM_Adrenal Hypofunction and hyperfunction_Slides.pptx
  • FP wk3 Overview of Homeostasis - AMC — draft_Overview of Homeostasis AK 2025.pptx p.26: | Renin-Angiotensin-Aldosterone System (RAAS) A diagram of the renin angiotensin aldosterone system (RAAS). Campbell 2025
  • RU wk2 Extracellular Na+ & H2O - AMC — Regulation of ECF Na and H2O_1.20.26.pptx p.25: | # Renin-Angiotensin-Aldosterone System Sodium retention Increased BP Angiotensinogen Renin Angiotensin I MR in collecting duct ACE Angiotensin II Aldosterone Adrenal Gland (Zona Glomerulosa)
  • EM wk4 Adrenal Hypofunction & Hyperfunction - AMC — Adrenal Hypo- & HyperfunctionAFTERCLASSFINAL.pptx p.21: | Diagram Description automatically generated Aldosterone secretion is regulated by RAAS Renin ↓ Angiotensinogen  Angiotensin I ↓  ACE Angiotensin II ↓ Aldosterone # Renin- Angiote

Q27: Is hypertension treatment taught in more than one course?

Query hypertension treatment antihypertensive · scope all courses AY25-26 · gold (none specified) · recall@10 10 hits

MeSH expansion added: High Blood Pressure, Treatments, Anti Hypertensive, Therapy, Anti Hypertensive Agent, Antihypertensive Drug, Anti-Hypertensives, Antihypertensive Drugs, Antihypertensives, Therapies

score course campus week event_title method title objective material top_file
2.71 RU AMC 2 Anti-hypertensives & Diuretics - AMC Lecture 1 0.85 0.86 SOM AntiHTN Diuretics 2026 final.pptx
2.17 RU FCB 2 Secondary Causes of Hypertension - FCB Lecture 0.6 0.7 0.87 2-00195-Secondary Causes of Hypertension_GCA_CONTENT_26.pdf
2.14 RU FCB 3 Small Group - Potassium Regulation & Hypertension - FCB Small Group 0.53 0.7 0.91 3-00315-K+ Regulation & Hypertension (Cases)_WITH_ANSWERS_26.pdf
2.07 RU FCB 2 Anti-hypertensives & Diuretics - FCB Lecture 0.58 0.85 0.64 2-00215-Antihypertensives & Diuretics_GCA_CONTENT_26.pdf
2 RU FCB 2 Hypertension - FCB Lecture 0.63 0.73 0.64 2-00190-Hypertension_GCA_CONTENT_26.pdf
2 RU AMC 2 Hypertension - AMC Lecture 0.61 0.73 0.66 Hypertension_Bansal_2026.pptx
1.94 RU AMC 2 Secondary Causes of Hypertension - AMC Lecture 0.64 0.7 0.61 Secondary_Hypertension_Bansal_2026.pptx
1.74 EM FCB 1 Intro to Obesity Treatment: Counseling, Diet, Medications & Surgery - FCB Lecture 0.35 0.39 1 1-20260520_1030-Intro to Obesity Treatment_CONTENT_GCA_26.pdf
1.63 RU AMC 3 Small Group - Potassium Regulation & Hypertension - AMC Small Group 0.53 0.7 0.4 Pre_Potassium and HTN Small Group 2025.doc
1.62 PCV AMC 6 Pulmonary Vascular Disease - AMC Lecture 0 1 0.62 Pulmonary Vascular Disease 2025.pptx
  • EM wk1 Intro to Obesity Treatment: Counseling, Diet, Medications & Surgery - FCB — 1-20260520_1030-Intro to Obesity Treatment_CONTENT_GCA_26.pdf p.41: | Q’s Question A 41-year-old individual with obesity and poorly controlled hypertension is being considered for pharmacologic weight loss therapy. Blood pressure is 168/98 mm Hg despite antihypertens
  • RU wk1 Overview of Renal Physiology - FCB — RU_BONUS_Practice Qustions_03_GCA_26.pdf p.21: | Question A 55-year-old individual presents to the clinic for evaluation of resistant hypertension. Despite adherence to three antihypertensive medications, including a diuretic, their blood pressur
  • RU wk3 Small Group - Potassium Regulation & Hypertension - FCB — 3-00315-K+ Regulation & Hypertension (Cases)_WITH_ANSWERS_26.pdf p.3: | LEARNING OBJECTIVE HELPER 1.1 AHA guideline-based initial antihypertensive therapy selection: Apply a guideline-consistent approach to initial pharmacologic therapy for hypertension based on blood

Q28: Where is beta-blocker pharmacology taught?

Query beta blocker · scope all courses AY25-26 · gold Autonomic Regulation, Antidysrhythmics, Heart Failure Treatment, Ischemia · recall@10 4/4

score course campus week event_title method title objective material top_file
1.94 PCV FCB 3 Acute Coronary Syndromes - Diagnosis & Management - FCB Lecture 0 1 0.94 3-00300-Acute Coronary Syndromes_CONTENT_GCA_25.pdf
1.86 PCV FCB 6 Principles of Heart Failure Treatment - FCB Lecture 0 0.88 0.98 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf
1.85 PCV AMC 3 Acute Coronary Syndromes - Diagnosis & Management - AMC Large Group 0 1 0.85 Acute Coronary Syndromes Part 2 Bricker - Complications and Management 2025.pptx
1.78 PCV AMC 2 ECG Cases: Cardiac Dysrhythmias - AMC Case-Based Instruction/Learning 0 0.86 0.92 Cardiac Dysrhythmias Clin Cases 2025 Answers version.pptx
1.59 PCV AMC 6 Principles of Heart Failure Treatment - AMC Lecture 0 0.88 0.71 Principles of Heart Failure Treatment - 2025 FINAL.pptx
1.49 PCV FCB 3 Ischemia, Angina & Claudication - FCB Lecture 0 0.57 0.92 3-00265-Ischemia, Angina & Claudication_CONTENT_GCA_25.pdf
1.4 PCV AMC 2 Pharmacology of Antidysrhythmics - AMC Lecture 0 0.47 0.93 Draft_Before_Antidysrythmic_09192025.pptx
1.31 PCV FCB 2 Pharmacology of Antidysrhythmics - FCB Lecture 0 0.47 0.84 2-00180-Pharmacology of Antiarrhythmic Drugs_CONTENT_GCA_25.pdf
1.09 PCV FCB 2 Autonomic Regulation of the Cardiovascular System - FCB Lecture 0 0.34 0.75 2-00145-Autonomic CV Regulation_CONTENT_GCA_25.pdf
1 RU AMC 2 Anti-hypertensives & Diuretics - AMC Lecture 0 0 1 SOM AntiHTN Diuretics 2026 final.pptx
  • RU wk2 Anti-hypertensives & Diuretics - AMC — SOM AntiHTN Diuretics 2026 final.pptx p.63: | # Beta Receptors Image result for beta blocker mechanism of action https://www.cvpharmacology.com/cardioinhibitory/beta-blockers
  • RU wk2 Regulation of Extracellular K+ - AMC — Potassium Regulation2026.pptx p.11: | Factors that lead to Extracellular Shifting of Potassium Non-selective Beta blockers 2 K+ ATP 3 Na+ [K+] B2 Beta blockers
  • PCV wk Principles of Heart Failure Treatment - FCB — 6-00630-Principles of Heart Failure Treatment_CONTENT_GCA_25 Fixed.pdf p.68: | C Case 6: Beta-blocker initiation in stable chronic HF A 58-year-old with stable HFrEF is ready for beta-blocker therapy after euvolemia is achieved. Why it matters clinically: Beta-blockers reduce

Q29: What changed in the Acute Coronary Syndromes session between AY24-25 and AY25-26?

Query acute coronary syndrome · scope PCV AY25-26 · gold Acute Coronary Syndromes · recall@10 1/1

MeSH expansion added: Symptom Clusters, Syndromes, Acute Coronary Syndromes, Symptom Cluster

score course campus week event_title method title objective material top_file
2.98 PCV AMC 3 Acute Coronary Syndromes - Diagnosis & Management - AMC Large Group 0.98 1 1 Acute Coronary Syndromes Part 1 Bricker - Diagnosis 2025.pptx
2.93 PCV FCB 3 Acute Coronary Syndromes - Diagnosis & Management - FCB Lecture 1 1 0.93 3-00300-Acute Coronary Syndromes_CONTENT_GCA_25.pdf
1.95 PCV AMC 3 Ischemia, Angina & Claudication - AMC Case-Based Instruction/Learning 0 1 0.95 M1 Event material for ischemia, angina, claudication 2025 FINAL.pptx
1.92 PCV FCB 3 Ischemia, Angina & Claudication - FCB Lecture 0 1 0.92 3-00265-Ischemia, Angina & Claudication_CONTENT_GCA_25.pdf
1.26 PCV AMC 3 PCV Anatomy Lab 8: Coronary & Peripheral Circulation, Thoracic Innervation - AMC Laboratory 0.38 0.41 0.47 DRAFT_before_PCV Wk3 Anatomy Lab #8_AY25-26.pptx
1.24 PCV FCB 3 PCV Anatomy Lab 8: Coronary & Peripheral Circulation, Thoracic Innervation - FCB Laboratory 0.35 0.41 0.48 11-17-25 FCB-PCV-Gross Anatomy Lab Coronary & Peripheral Circulation, Thoracic Innervation.pptx
1.22 PCV FCB 3 Pathology Lab: Pathology of Atherosclerosis, Ischemia & Infarction - FCB Small Group 0 0.29 0.93 3-00275-Ischemia & Infarction Path_CONTENT_GCA_25.pdf
1.13 PCV FCB 1 Cardiac Conduction & ECG Intro - FCB Lecture 0 0.55 0.58 1-00060-Cardiac Conduction & ECG Intro_CONTENT_GCA_25.pdf
1.1 PCV AMC 3 Pathology Lab: Pathology of Atherosclerosis, Ischemia & Infarction - AMC Small Group 0 0.29 0.81 Atherosclerosis, Ischemia and Infarction Facilitator slides with notes pages.pdf
1.06 PCV AMC 1 Cardiac Conduction & ECG Intro - AMC Lecture 0 0.55 0.51 Cardiac conduction and ECG intro 2025 FINAL.pptx
  • PCV wk3 Acute Coronary Syndromes - Diagnosis & Management - AMC — Acute Coronary Syndromes Part 1 Bricker - Diagnosis 2025.pptx p.2: | # Learning Objectives Discuss the pathophysiology of acute coronary syndromes, how different types of acute coronary syndromes (unstable angina, non-ST-elevation MI, and ST-elevation MI) differ fro
  • PCV wk3 Ischemia, Angina & Claudication - AMC — M1 Event material for ischemia, angina, claudication 2025 FINAL.pptx p.46: | # Acute Coronary Syndromes and Acute Limb Ischemia: Definitions Acute coronary syndrome (ACS) = combination of chest discomfort at rest, ECG changes, and / or biomarker elevation Acute limb ischemi
  • PCV wk3 Acute Coronary Syndromes - Diagnosis & Management - FCB — 3-00300-Acute Coronary Syndromes_CONTENT_GCA_25.pdf p.17: | 1 7 Acute coronary syndrome

Q30: How different are AMC and FCB materials for the Tuberculosis session?

Query tuberculosis · scope PCV AY25-26 · gold Tuberculosis · recall@10 1/1

MeSH expansion added: Koch Disease, Kochs Disease, Mycobacterium tuberculosis Infection, Mycobacterium tuberculosis Infections, Tuberculoses, Koch’s Disease

score course campus week event_title method title objective material top_file
2.93 PCV FCB 5 Tuberculosis - FCB Lecture 1 0.95 0.99 Tuberculosis (2025) - posted.pptx
2.57 PCV AMC 5 Tuberculosis - AMC Lecture 0.62 0.95 1 tuberculosis 2025.pptx
1.69 PCV AMC 5 PCV Week 5: Prework - AMC Directed Independent Learning 0 1 0.69 PCV CT Chest Prework w audio 2024.pptx
1 PCV FCB 5 PCV Week 5: Prework - FCB Directed Independent Learning 0 1 0 nan
0.96 PCV AMC 4 Immunology: Pulmonary Host Defense - AMC Large Group 0 0 0.96 PCV. Pulmonary Host Defense 2025_before class_FINAL.pptx
0.83 PCV AMC 4 Microbiology of Lung Infections: Bacterial Pneumonia - AMC Lecture 0 0 0.83 Bacterial Pneumonia Janoff 2025.pptx
0.81 PCV AMC 5 Pathology Lab: Histology & Pathology of Thoracic Malignancy & Benign Nodular Lesions - AMC Case-Based Instruction/Learning 0 0 0.81 AFTER_Thoracic Malignancy and Benign Nodular Lesions answers.pdf
0.8 PCV AMC 5 Pathologic Findings on CT Scans - AMC Lecture 0 0 0.8 Pathologic findings on CT 2025 FINAL.pptx
0.8 PCV FCB 5 Pathologic Findings on CT Scans - FCB Lecture 0 0 0.8 Pathologic findings on CT 2025 FINAL.pptx
0.77 PCV AMC 6 Pathology Lab: Heart Failure and Cardiomyopathy - AMC Laboratory 0 0 0.77 AFTER_Heart Failure and Cardiomyopathy answers.pdf
  • PCV wk5 Tuberculosis - AMC — tuberculosis 2025.pptx p.2: | # Learning Objectives Differentiate between the clinical features of and diagnostic studies for latent and reactivation TB. Discuss the epidemiology, microbiology and pathogenesis of M. tuberculosi
  • PCV wk5 Tuberculosis - FCB — Tuberculosis (2025) - posted.pptx p.2: | # Learning Objectives List common infectious causes of hemoptysis. Differentiate between the clinical features of and diagnostic studies for latent and reactivation TB. Discuss the epidemiology, mi
  • PCV wk4 Immunology: Pulmonary Host Defense - AMC — PCV. Pulmonary Host Defense 2025_before class_FINAL.pptx p.32: | TUBERCULOSIS Picture 6 A few EXAMPLES of ONE-PAGE VISUALS ABOUT TB Picture 8 https://andrecaetano.com/portfolio/voyages-in-tuberculosis/ https://www.behance.net/ga

Q31: I’m writing a new session on pulmonary hypertension. What already exists (objectives, sessions, prerequisites)?

Query pulmonary hypertension · scope all courses AY25-26 · gold Pulmonary Vascular Disease · recall@10 1/1

MeSH expansion added: High Blood Pressure, High Blood Pressures

score course campus week event_title method title objective material top_file
2.73 PCV FCB 6 Pulmonary Vascular Disease - FCB Lecture 0.73 1 1 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25 Fixed.pdf
2.55 PCV AMC 6 Pulmonary Vascular Disease - AMC Lecture 0.61 1 0.93 Pulmonary Vascular Disease 2025.pptx
2.24 RU FCB 2 Hypertension - FCB Lecture 0.99 0.68 0.57 2-00190-Hypertension_GCA_CONTENT_26.pdf
2.23 RU AMC 2 Secondary Causes of Hypertension - AMC Lecture 1 0.63 0.59 Secondary_Hypertension_Bansal_2026.pptx
2.17 RU AMC 2 Hypertension - AMC Lecture 0.96 0.68 0.54 Hypertension_Bansal_2026.pptx
2.04 RU FCB 2 Secondary Causes of Hypertension - FCB Lecture 0.95 0.63 0.45 2-00195-Secondary Causes of Hypertension_GCA_CONTENT_26.pdf
1.99 PCV AMC 5 Immunology: Autoimmune Lung Disease, Sinus Disease & Hemorrhage - AMC Large Group 0.51 0.54 0.94 PCV. Autoimmune Lung Disease 2025_before class_FINAL.pptx
1.98 PCV FCB 1 Pulmonary + Systemic Circulation - FCB Lecture 0.73 0.59 0.66 FCB-PCV-Circulatory Physiology-FA25-AC.pptx
1.96 PCV AMC 1 Pulmonary + Systemic Circulation - AMC Lecture 0.69 0.59 0.68 Circulation talk 2025.pptx
1.91 RU FCB 3 Small Group - Potassium Regulation & Hypertension - FCB Small Group 0.83 0.6 0.47 3-00315-K+ Regulation & Hypertension (Cases)_WITH_ANSWERS_26.pdf
  • PCV wk Pulmonary Vascular Disease - FCB — 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25 Fixed.pdf p.39: | Q’s Question A 59-year-old individual presents with progressive dyspnea and lower-extremity edema. Echocardiography shows elevated right ventricular systolic pressure and mild right ventricular enl
  • PCV wk6 Pulmonary Vascular Disease - FCB — 6-00635-Pulmonary Vascular Disease_CONTENT_GCA_25.pdf p.39: | Q’s Question A 59-year-old individual presents with progressive dyspnea and lower-extremity edema. Echocardiography shows elevated right ventricular systolic pressure and mild right ventricular enl
  • PCV wk1 Normal Lung Histology & Pathology of Impaired Gas Exchange - AMC — AFTER_Normal lung histology and pathology of gas exchange answers.pdf p.31: | Q4. How does pulmonary fibrosis reduce A) Normal Reference Pulmonary Arteriole B) Pulmonary hypertension ventilation and oxygenation? Patients with pulmonary fibrosis can also develop increased pre

Q32: What have students already learned about acid-base physiology before the PCV blood gas session?

Query acid base · scope all courses AY25-26 · gold (none specified) · recall@10 10 hits

MeSH expansion added: Acids

score course campus week event_title method title objective material top_file
3 RU AMC 2 Acid Base Disorders - AMC Lecture 1 1 1 Final_Clinical Acid Base_Bansal_2026.pptx
2.9 RU FCB 2 Acid Base Disorders - FCB Lecture 0.97 1 0.93 2-00170-Acid Base Disorders_GCA_CONTENT_26.pdf
2.52 RU AMC 2 Role of Kidney in Acid Base Balance - AMC Lecture 0.96 0.59 0.97 Final_Kidney in acid base_Bansal_2026.pptx
2.41 RU FCB 2 Role of Kidney in Acid Base Balance - FCB Lecture 0.89 0.59 0.93 2-00165-Role of Kidney in Acid Base Balance_GCA_CONTENT_26.pdf
1.97 RU AMC 3 RU Week 3: Prework - AMC Directed Independent Learning 0 1 0.97 Pre_Acid Base Small Groups 2025 (2) (1) (1).doc
1.89 RU AMC 3 Small Group - Acid/Base Pathophysiology - AMC Small Group 0.92 0 0.97 Pre_Acid Base Small Groups 2025.doc
1.86 FP AMC 3 Overview of Homeostasis - AMC Lecture 0.5 0.66 0.7 draft_Overview of Homeostasis AK 2025.pptx
1.82 RU FCB 3 Small Group - Acid/Base Pathophysiology - FCB Small Group 0.89 0 0.93 3-00305-Acid-Base Pathophysiology (Cases)_NO_ANSWERS_26.pdf
1.7 PCV AMC 1 PCV Clinical Cases: ABG, PFT, ECG - AMC Case-Based Instruction/Learning 0 0.77 0.92 Clinical Cases ABG-PFT-ECG 2025 - release to students AFTER event.pptx
1.69 RU AMC 3 Acid/Base Cases Pathophysiology - AMC nan 0.75 0.95 0 nan
  • RU wk2 Acid Base Disorders - AMC — Final_Clinical Acid Base_Bansal_2026.pptx p.22: | What is the second acid-base disorder ? | Primary Acid Base Disorder | How to Identify Second Acid Base Disorder? | Second Acid Base Disorder | | — | — | — | | Respiratory Alkalosis OR Respir
  • RU wk2 Role of Kidney in Acid Base Balance - AMC — Final_Kidney in acid base_Bansal_2026.pptx p.43: | # Summary – Acid-Base Balance Renally secreted H+ must be buffered in urine Titratable acid Ammonia trapping Renal handling of acid is regulated by ECF pH and CO2 Transporters for H+ and HCO3- are
  • PCV wk1 Blood Gas Analysis: Gas Exchange & Respiratory Failure - AMC — A Practical Clinical Approach to the Analysis of Acid-Base Disorders and Respiratory Failure v2.2 - HIGHLY OPTIONAL.pdf p.5: | NORMAL ACID BASE PHYSIOLOGY Before discussing acid-base and respiratory derangements, let’s review some normal physiology. The respiratory and renal systems are the primary regulators of acid-base